DEC 2023
Atopic Dermatitis (Eczema) Guidelines (GRADE)
Ann Allergy Asthma Immunol . 2023 Dec 18:S1081-1206(23)01455-2.
Abstract
Guidance addressing atopic dermatitis (AD) management, last issued in 2012 by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force, requires updating as a result of new treatments and improved guideline and evidence synthesis methodology.
Click Below to Read the Full Publication
Supplemental Material
Atopic Dermatitis PowerPoint 2024 Update
Bleach baths - JTF AD Guideline Supplement
Dietary elimination - JTF AD Guideline Supplement
Allergen Immunotherapy - JTF AD Guideline Supplement
Moisturizers - JTF AD Guideline Supplement
Topical Corticosteroids (TCS) - JTF AD Guideline Supplement
Wet wrap (occlusive) therapy - JTF AD Guideline Supplement
Topical calcineurin inhibitors (TCIs) - JTF AD Guideline Supplement
Once versus twice daily TCS or TCI - JTF AD Guideline Supplement
PDE4 inhibitors - Crisaborole - JTF AD Guideline Supplement
Topical JAK inhibitors - JTF AD Guideline Supplement
Topical antimicrobials - JTF AD Guideline Supplement
Biologics - JTF AD Guideline Supplement
Oral (Systemic) JAK inhibitors - JTF AD Guideline Supplement
Azathioprine - JTF AD Guideline Supplement
Cyclosporine - JTF AD Guideline Supplement
Methotrexate - JTF AD Guideline Supplement
Mycophenolate - JTF AD Guideline Supplement
Narrow-band UVB (NB-UVB) - JTF AD Guideline Supplement
Systemic (oral) corticosteroids - JTF AD Guideline Supplement